Access cutting-edge advanced melanoma treatment through this clinical trial at a research site in Kingman. Study-provided care at no cost to qualified participants.
Access advanced melanoma specialists in Kingman at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced melanoma treatment provided free
This phase II/III trial studies the side effects of nivolumab and ipilimumab when given together with or without sargramostim and to see how well they work in treating patients with stage III-IV melanoma that cannot be removed by surgery (unresectable) and that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Immunotherapy with monoclonal antibodies, such as ipilimumab and nivolumab, may help the body's immune system attack the c
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this advanced melanoma clinical trial in Kingman, AZ
If you're searching for advanced melanoma treatment options in Kingman, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kingman research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.